A
ALVO
Alvotech
4.170
-0.050-1.18%After Hours: 4.250 +0.080 +1.92%19:10 06/12 EDT
OPEN/PREV CLOSE4.310/4.220
TODAY RANGE4.155-4.450
VOL533.76K
MARKET CAP1.30B
52 WEEK RANGE2.940-10.78
AVG VOL (3M)566.40K
% TURNOVER0.17%
TURNOVER--
P/E (TTM)-14.8504
% RANGE6.93%
EPS(TTM)-0.2808
P/E(FORWARD)10.42
P/B-4.6108
BVPS-0.9044
DIVIDEND--
P/S2.209
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP479.69M
SHARES OUTSTANDING312.15M
NEXT EARNINGS03/24-03/30
FREE FLOAT115.03M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Barchart·3d ago
Transactions of Managers and Closely Associated Persons
Seeking Alpha·3d ago
Small-cap sell streaks: 10 stocks trapped longest in bearish Quant ratings
Seeking Alpha·5d ago
Alvotech: Speculative 'Buy' Despite The FDA's CMC Requirements
Seeking Alpha·5d ago
Biggest stock movers Monday: NRIX, HON, and more
TipRanks·5d ago
Alvotech announces FDA acceptance of AVT16 BLA for review
Seeking Alpha·5d ago
Alvotech gains on FDA acceptance of Entyvio biosimilar BLA
NASDAQ·06/05 17:31
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
Seeking Alpha·06/04 18:34
Alvotech seeks U.S. nod for biosimilars to J&J’s Simponi and Regeneron’s Eylea again
TipRanks·06/04 14:10
Alvotech Resubmits Key U.S. Biosimilar Applications After 2026 AGM Approvals
NASDAQ·06/04 11:02
Alvotech And Teva Resubmit BLAs To FDA For Biosimilars AVT05 And AVT06
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.